article thumbnail

Liability for COVID-19 Vaccine Harms: We Need to Do Better

Bill of Health

COVID-19 vaccines are extremely safe , and serious harms are rare. But rare does not mean the risk is zero; thus, we need a way to determine which people have plausible claims of harm from the vaccines, and we must then compensate them quickly and generously. By Dorit Reiss. Nevertheless, rare injuries do happen.

article thumbnail

Remember the Babies: The Need for Off-Label Pediatric Use of COVID-19 Vaccines

Bill of Health

Centers for Disease Control and Prevention (CDC) is failing parents by preventing off-label use of our existing COVID-19 vaccines in the under-five set. The CDC, through its vaccine provider agreements, prevents physicians and parents from pursuing off-label use of COVID-19 vaccinations in young children.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What Happened to the COVID-19 Vaccine Patent Waiver?

Bill of Health

In June 2022, after almost two years of debate over a potential COVID-19 vaccine patent waiver, the World Trade Organization adopted the Ministerial Decision on the TRIPS Agreement (“WTO Decision”), which provided for a partial waiver of intellectual property rights. By Sarah Gabriele. appeared first on Bill of Health.

article thumbnail

Georgia's COVID-19 vaccination efforts boosted by scalable reg and booking tools

Healthcare It News

The Community Organized Relief Effort in Georgia, better known as CORE, had a major operational challenge to coordinate all the logistical issues of setting up mobile vaccinations for COVID-19 across an entire state and managing dozens of field teams at more than 100 different locations. THE PROBLEM. Enterprise Taxonomy:

article thumbnail

COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues

Bill of Health

Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. Interestingly, as of January 12, 2023, Moderna has listed 10 patents covering Spikevax (its mRNA vaccine) on its website.

article thumbnail

Pfizer forecasts $100B in sales, fueled by COVID-19 vaccine, pill

Healthcare Dive

The company estimated revenue from its COVID-19 vaccine and new antiviral pill Paxlovid will total $54 billion this year.

article thumbnail

Funds for free COVID-19 vaccines could run out as early as January, HHS says

Healthcare Dive

The commercial market for COVID-19 vaccinations could be similar to that for seasonal flu shots and other vaccines, the department said.